Skip to content

The Microcirculation in Acute Myocardial Infarction (Micro-AMI)

The Microcirculation in Acute Myocardial Infarction (Micro-AMI)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01552564
Acronym
Micro-AMI
Enrollment
50
Registered
2012-03-13
Start date
2012-03-31
Completion date
Unknown
Last updated
2014-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI

Brief summary

This study investigates the association between the microvascular resistance at the time of primary percutaneous intervention, with microvascular obstruction on CMR and blood markers of myocardial damage.

Interventions

Sponsors

University of Bristol
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>18 years old * Cardiac symptoms of \> 20 mins chest pain or equivalent. * ECG criteria consistent with STEMI (STEMI) * Proceeding with percutaneous angioplasty * Assent/ consent to the study

Exclusion criteria

* Known allergy to adenosine or gadolinium * Chronic atrial fibrillation * Renal impairment with eGFR \<30 * Contraindication to angiography * Contraindication to CMR (implanted pacemaker/ defibrillator, ferromagnetic metal implant/ injury, claustrophobia, obesity/ too large for CMR scanner) * Cardiogenic shock * Patients with special communication needs or altered consciousness. * Patients who do not give assent/consent to the study

Design outcomes

Primary

MeasureTime frameDescription
Microvascular obstructionDAy 2-4Microvascular obstruction as a percentage of the left ventricle at 2-4 days.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026